alexa Brachyury Goes Clinical

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Brachyury Goes Clinical

It takes several years, for a gene of interest in basic science to get into clinical trial. These developments are much hoped for but never are easy and certainly not fast. These steps usually involve many years of basic science research, financial support and yet no conclusion for a clinical trial. One of the genes, which climbed these steps very fast, is the mesoderm-inducing gene and T-box transcription factor ‘Brachyury’. Brachyury was not studied extensively in cancer until the recent years. Its role in the cancer was merely known until very recently.


Citation: Sarkar D (2013) Brachyury Goes Clinical. Transcriptomics 1:e101. doi: 10.4172/2329-8936.1000e101

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger